Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Quantification of metabolic limitations during recombinant protein production in Escherichia coli.

J Biotechnol.. 2011-09;  155(2):178-84
Heyland J, Blank LM, Schmid A. a Laboratory of Chemical Biotechnology, TU Dortmund University, 44227 Dortmund, Germanyb Leibniz-Institut für Analytische Wissenschaften – ISAS – e. V., 44139 Dortmund, Germany
Products/Services Used Details Operation

摘要

Escherichia coli is one of the major microorganisms for recombinant protein production because it has been best characterized in terms of molecular genetics and physiology, and because of the availability of various expression vectors and strains. The synthesis of proteins is one of the most energy consuming processes in the cell, with the result that cellular energy supply may become critical. Indeed, the so called metabolic burden of recombinant protein synthesis was reported to cause alterations in the operation of the host's central carbon metabolism.To quantify these alterations in E. coli metabolism in dependence of the rate of recombinant protein production, 13C-tracer-based metabolic flux analysis ... More

关键词

MFA; Flux probe; Metabolic network analysis; 13C flux analysis; Recombinant protein production
XML 地图